Under the name Zometa, the drug was approved by the U. S. Food and Drug Administration for cancer patients in 2002.
药名为唑来膦酸，该药在2002年被美国 FDA获准用于癌症病人恶性高血钙的治疗。
Under the name Zometa, the drug was approved by the U. S. Food and Drug Administration for cancer patients in 2002.
药名为唑来膦酸，该药在2002年被美国 FDA获准用于癌症病人恶性高血钙的治疗。
应用推荐